Donafenib
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC (NCT05205629) | Shanghai Zhongshan Hospital | 2022-01-30 |
| A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice (NCT05200221) | Shanghai Zhongshan Hospital | 2022-01-19 |
| Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery (NCT04962958) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-12-27 |
| A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC (NCT05262959) | Shanghai Zhongshan Hospital | 2021-12-01 |
Track Donafenib automatically
Every clearance here is in the API, with alerts when new ones post.